{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:16:14Z","timestamp":1765887374383,"version":"3.44.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008562","name":"University of Texas at Austin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008562","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005570","name":"Takeda Pharmaceuticals North America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005570","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.clinthera.2012.01.020","type":"journal-article","created":{"date-parts":[[2012,3,6]],"date-time":"2012-03-06T02:16:38Z","timestamp":1331000198000},"page":"640-652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Evaluation of Health Care Costs and Utilization Patterns for Patients With Gout"],"prefix":"10.1016","volume":"34","author":[{"given":"Haesuk","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen L.","family":"Rascati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Prasla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tyrone","family":"McBayne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2012.01.020_bib1","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0149-2918(03)80158-3","article-title":"A literature review of the epidemiology and treatment of acute gout","volume":"25","author":"Kim","year":"2003","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2012.01.020_bib2","first-page":"2403","article-title":"Epidemiology of gout: is the incidence rising?","volume":"29","author":"Arromdee","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinthera.2012.01.020_bib3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/01.bor.0000209435.89720.7c","article-title":"New insights into gout epidemiology","volume":"18","author":"Mikuls","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clinthera.2012.01.020_bib4","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","article-title":"Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008","volume":"63","author":"Zhu","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clinthera.2012.01.020_bib5","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1185\/030079906X112606","article-title":"The economic burden of gout on an employed population","volume":"22","author":"Brook","year":"2006","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2012.01.020_bib6","first-page":"2050","article-title":"A survey of current evaluation and treatment of gout","volume":"33","author":"Schlesinger","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinthera.2012.01.020_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/01.bor.0000162060.25895.a5","article-title":"Recent advances in the management of gout and hyperuricemia","volume":"17","author":"Wortmann","year":"2005","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clinthera.2012.01.020_bib8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/01.rhu.0000209882.50228.9f","article-title":"Serum urate levels and gout flares: analysis from managed care data","volume":"12","author":"Sarawate","year":"2006","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.clinthera.2012.01.020_bib9","first-page":"164","article-title":"Disease-related and all-cause health care costs of elderly patients with gout","volume":"14","author":"Wu","year":"2008","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.clinthera.2012.01.020_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/RHU.0b013e3181945d2c","article-title":"The effect of serum urate on gout flares and their associated costs: an administrative claims analysis","volume":"15","author":"Halpern","year":"2009","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.clinthera.2012.01.020_bib11","doi-asserted-by":"crossref","first-page":"925","DOI":"10.4065\/81.7.925","article-title":"Gout medication treatment patterns and adherence to standards of care from a managed care perspective","volume":"81","author":"Sarawate","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clinthera.2012.01.020_bib12","first-page":"1575","article-title":"Compliance with allopurinol therapy among managed care enrollees with gout: a retrospective analysis of administrative claims","volume":"31","author":"Riedel","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clinthera.2012.01.020_bib13","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/ar2659","article-title":"Adherence with urate-lowering therapies for the treatment of gout","volume":"11","author":"Harrold","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.clinthera.2012.01.020_bib14","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1185\/03007990903017966","article-title":"Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis","volume":"25","author":"Halpern","year":"2009","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2012.01.020_bib15","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jclinepi.2008.01.006","article-title":"The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients","volume":"61","author":"Charlson","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.clinthera.2012.01.020_bib16","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/00005650-199508000-00004","article-title":"A chronic disease score with empirically derived weights","volume":"33","author":"Clark","year":"1995","journal-title":"Med Care"},{"key":"10.1016\/j.clinthera.2012.01.020_bib17","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1524-4733.2008.00343.x","article-title":"The estimation power of alternative comorbidity indices","volume":"11","author":"Baser","year":"2008","journal-title":"Value Health"},{"key":"10.1016\/j.clinthera.2012.01.020_bib18","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/j.clinthera.2009.11.030","article-title":"Validity of the adherence estimator in the prediction of 9-month persistence with medications prescribed for chronic diseases: a prospective analysis of data from pharmacy claims","volume":"31","author":"McHorney","year":"2009","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2012.01.020_bib19","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1345\/aph.1K671","article-title":"Contrasting measures of adherence with simple drug use, medication switching, and therapeutic duplication","volume":"43","author":"Martin","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinthera.2012.01.020_bib20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","article-title":"Medication compliance and persistence: terminology and definitions","volume":"11","author":"Cramer","year":"2008","journal-title":"Value Health"},{"key":"10.1016\/j.clinthera.2012.01.020_bib21","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0167-6296(98)00030-7","article-title":"Much ado about two: reconsidering retransformation and the two-part model in health econometrics","volume":"17","author":"Mullahy","year":"1998","journal-title":"J Health Econ"},{"key":"10.1016\/j.clinthera.2012.01.020_bib22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0167-6296(01)00086-8","article-title":"Estimating log models: to transform or not to transform?","volume":"20","author":"Manning","year":"2001","journal-title":"J Health Econ"},{"key":"10.1016\/j.clinthera.2012.01.020_bib23","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMcp030733","article-title":"Gout","volume":"349","author":"Terkeltaub","year":"2003","journal-title":"N Engl J Med"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291812000665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291812000665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:48:38Z","timestamp":1758962918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291812000665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S0149291812000665"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2012.01.020","relation":{},"ISSN":["0149-2918"],"issn-type":[{"type":"print","value":"0149-2918"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Health Care Costs and Utilization Patterns for Patients With Gout","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2012.01.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier HS Journals, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}